All Articles
Think you know all the facts about Triple-Negative Breast Cancer? Think again. Increase your knowledge by checking out these common myths. Read More ›
Ricki Fairley was told she had 2 years to live. That was 8 years ago. This is her inspiring story of survival. Read More ›
Sharing the news of a diagnosis with your family, friends, and coworkers is hard. But you have total control over how and when these conversations take place. Here’s a guide of what to expect. Read More ›
Your nurse navigator is the key person on your healthcare team to connect with throughout the entire course of your experience. Here’s why. Read More ›
An intimate discussion about what palliative care is, what is isn’t, and why it’s valuable to breast cancer patients. Read More ›
Cancer care is not a one-size-fits-all approach. Part of a successful, personalized treatment plan includes an engaged and empowered you! Read More ›
There are important changes to beneficiaries’ Medicare Part D prescription drug coverage for 2020. These changes can affect how much patients must pay out of pocket for their medications, including certain cancer drugs. Read More ›
In an updated analysis of 134 patients with relapsed/refractory chronic lymphocytic leukemia (CLL) who were treated with acalabrutinib monotherapy, more than 90% were still responding after 41 months of treatment. Read More ›
Patients with chronic lymphocytic leukemia or mantle-cell lymphoma who were started on acalabrutinib in the United States had high rates of comorbid hypertension and other hematologic malignancies, and about two-thirds received prior ibrutinib. Read More ›
In shared decision-making, patients communicate their preferences and values to their healthcare team when treatment decisions are made. Patients who take an active role in the process tend to be more satisfied with their quality of care. Read More ›